Open Access
Research Paper
Peer Reviewed

Paper Title

Anti-cancer activity of 1,3,4-oxadiazole and its derivative

Article Identifiers

Registration ID: IJNRD_206247

Published ID: IJNRD2310013

: https://doi.org/10.5281/zenodo.12743599

Keywords

Oxadiazole ring , anticancer activity , HDAC , Proliferation , anti-tumor

Abstract

Nowadays cancer is a leading cause of death, the most common cancers worldwide are breast, colorectal, and lung cancer. Data from the International agency for Research on Cancer (IARC) says 19.3 million new cases of cancer and 10 million deaths. Oxidaizole derivatives are compounds having 5-membered rings containing one oxygen and two nitrogen atoms such as oxacillin, sulfamethoxazole, acivicin, and cycloserine have containing oxadiazole ring . 1,3,4 oxadiazole derivatives have the demand for researchers because of their various activities such as antibacterial, anti-tumor, antiviral, and antioxidant. Nowadays there are potent medicines in the market having anticancer activity, used worldwide. Some examples of anticancer agents available in the market are bleomycin and tiazofurin. There are some various mechanisms of action of 1,3,4 oxadiazole derivatives for anticancer activity, by acting on some enzymes likes thymidylate-syn-thase, HDAC(histone deacetylase ), topoisomerase II, telomerase, thymidine phosphorylase to stop proliferation and also acting some pathways likes inhibiting telomerase activity, focal adhesion kinase(FAK) inhibitors, targeting thymidylate synthase, an inhibitor of the B-cell lymphoma 2, inhibitor of NF-kB signaling pathway and targeting tubulin polymerization. So,1,3,4-oxadiazole used as a promising anticancer drug in future.

How To Cite (APA)

KOUSIK MAPARU, RITAM MUKHERJEE, & DHRITA CHATTERJEE (October-2023). Anti-cancer activity of 1,3,4-oxadiazole and its derivative. INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(10), a84-a95. https://doi.org/10.5281/zenodo.12743599

Citation

Issue

Other Publication Details

Paper Reg. ID: IJNRD_206247

Published Paper Id: IJNRD2310013

Downloads: 000122007

Research Area: Pharmacy

Author Type: Indian Author

Country: East Medinipur , West Bengal , India

Published Paper PDF: https://ijnrd.org/papers/IJNRD2310013.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2310013

Crossref DOI: https://doi.org/10.5281/zenodo.12743599

About Publisher

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

Copyright & License

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.

You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.
CC OpenContant

Publication Timeline

Peer Review
Through Scholar9.com Platform

Article Preview: View Full Paper

Call For Paper

Call For Paper - Volume 10 | Issue 11 | November 2025

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

How to submit the paper?

You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.


For more details, refer to the official notice: UGC Public Notice


Submit Paper Online

Important Dates for Current issue

Paper Submission Open For: November 2025

Current Issue: Volume 10 | Issue 11 | November 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 30-Nov-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details

Approval, Licenses and Indexing: More Details